(Q39743152)

English

The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Moeketsi Mokete

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

David C Shackley

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Christopher D Betts

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Kieran J O'Flynn

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

266-269

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Evidence of prostate cancer screening in a UK region

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Socioeconomic status within social class and mortality: a prospective study in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Changing relationship between socioeconomic status and prostate cancer incidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

DECLINE IN PROSTATE CANCER MORTALITY FROM 1980 TO 1997, AND AN UPDATE ON INCIDENCE TRENDS IN OLMSTED COUNTY, MINNESOTA

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.06011.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2005.06011.X

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39743152&oldid=2089261373"